The stock price of Regencell Bioscience Holdings Ltd (NASDAQ: RGC) has dropped by -26.38 compared to previous close of 34.87. Despite this, the company has seen a fall of -56.22% in its stock price over the last five trading days. globenewswire.com reported 2025-03-28 that ROANOKE, Va., March 28, 2025 (GLOBE NEWSWIRE) — The Board of Directors of RGC Resources, Inc. (NASDAQ: RGCO) declared a quarterly dividend of $0.2075 per share on the Company’s common stock. The dividend will be paid on May 1, 2025 to shareholders of record on April 17, 2025. This is the Company’s 324th consecutive quarterly cash dividend.
Is It Worth Investing in Regencell Bioscience Holdings Ltd (NASDAQ: RGC) Right Now?
Additionally, the 36-month beta value for RGC is -3.92. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 1 rating it as “sell.”
The public float for RGC is 0.80M and currently, short sellers hold a 37.16% ratio of that float. The average trading volume of RGC on March 31, 2025 was 669.60K shares.
RGC’s Market Performance
The stock of Regencell Bioscience Holdings Ltd (RGC) has seen a -56.22% decrease in the past week, with a 428.19% rise in the past month, and a 396.23% gain in the past quarter. The volatility ratio for the week is 43.12%, and the volatility levels for the past 30 days are at 40.40% for RGC. The simple moving average for the past 20 days is 20.19% for RGC’s stock, with a 248.58% simple moving average for the past 200 days.
RGC Trading at 131.79% from the 50-Day Moving Average
After a stumble in the market that brought RGC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.80% of loss for the given period.
Volatility was left at 40.40%, however, over the last 30 days, the volatility rate increased by 43.12%, as shares surge +458.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +430.37% upper at present.
During the last 5 trading sessions, RGC fell by -56.22%, which changed the moving average for the period of 200-days by +369.29% in comparison to the 20-day moving average, which settled at $21.36. In addition, Regencell Bioscience Holdings Ltd saw 419.64% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for RGC
The total capital return value is set at -0.29. Equity return is now at value -42.49, with -40.85 for asset returns.
Currently, EBITDA for the company is -3.62 million with net debt to EBITDA at 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 41.92.
Conclusion
In conclusion, Regencell Bioscience Holdings Ltd (RGC) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
